Mckesson (MCK) Cash from Financing Activities (2009 - 2026)
Mckesson (MCK) posted quarterly Cash from Financing Activities of -$2.8 billion for Q1 2026, up 1.23% year-over-year from -$2.8 billion in Q1 2025, and down 39.19% quarter-over-quarter from -$2.0 billion in Q4 2025.
Mckesson (MCK) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported Cash from Financing Activities for 18 consecutive years, with -$2.8 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 1.23% year-over-year to -$2.8 billion; the TTM figure through Mar 2026 stood at -$4.6 billion (down 16.8% YoY), while the FY2026 annual figure was -$4.6 billion, down 16.8% from the prior year.
- Cash from Financing Activities eased to -$2.8 billion in Q1 2026 per MCK's latest filing, from -$2.0 billion in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.3 billion in Q4 2024 and bottomed at -$2.9 billion in Q1 2025.
- Historically, Cash from Financing Activities has averaged -$1.1 billion across 5 years, with a median of -$968.0 million in 2024.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 284.72% — and 2024, when it soared 308.68%.
- Mckesson's Cash from Financing Activities stood at -$1.4 billion in 2022, then soared by 56.35% to -$622.0 million in 2023, then soared by 308.68% to $1.3 billion in 2024, then tumbled by 256.09% to -$2.0 billion in 2025, then sank by 39.19% to -$2.8 billion in 2026.
- Business Quant data shows MCK's Cash from Financing Activities at -$2.8 billion in Q1 2026, -$2.0 billion in Q4 2025, and -$961.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1.63 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -1.77 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | -490.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -168.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 11.77 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -271.98 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -17.69 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 1.79 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Bn |
| Jun 30, 2026 | 1.63 Bn |
| Mar 31, 2026 | -2.82 Bn |
| Mar 31, 2026 | -2.82 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Sep 30, 2025 | -961.00 Mn |
| Sep 30, 2025 | -961.00 Mn |
| Jun 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Jun 30, 2024 | -809.00 Mn |
| Jun 30, 2024 | -809.00 Mn |
| Mar 31, 2024 | -968.00 Mn |
| Mar 31, 2024 | -968.00 Mn |